Evidence map›Paper›PMID 37489189›Full record

ArticleCureus2023

COVID-Induced Hyperthyroidism in a 30-Year-Old Female: A Case Study.

Benjamin Ilyaev, Sabina N Muminiy, Emmanuella Borukh, Emmanuel Izrailov, Yakubmiyer Musheyev, Stella Ilyayeva

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Benjamin IlyaevMedicine, Hofstra University, Hempstead, USA.
Sabina N MuminiyMedicine, St. Francis College, New York City, USA.
Emmanuella BorukhMedicine, Yeshiva University, New York City, USA.
Emmanuel IzrailovMedicine, Touro College, New York City, USA.
Yakubmiyer MusheyevMedicine, New York Institute of Technology College of Osteopathic Medicine (NYITCOM), Old Westbury, USA.
Stella IlyayevaEndocrinology and Diabetes, Atlantic Endocrinology and Diabetes Center, New York City, USA.
Hofstra University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thyroiditis should be in the differential for hyperthyroidism when thyroid-stimulating hormone (TSH) is suppressed and T3/T4 levels are elevated. Suspicion of hyperthyroidism is further increased when the patient can exhibit symptoms such as weight loss, anxiety, feeling feverish, tremors, shaking, and sweating. Hyperthyroidism is generally classified as being overt or subclinical. In the following case, the patient had overt hyperthyroidism which is considered more severe than subclinical hyperthyroidism. Coronavirus disease is not typically associated with thyroiditis; however, in this case, the patient's disorder was accidentally found on her blood results which were originally taken due to her coronavirus disease 2019 (COVID-19) diagnosis.  In this case study, we present a 30-year-old female patient, with suspicions of COVID-19-induced hyperthyroidism found incidentally on her blood panel. An original diagnosis of thyroiditis was made prior to the visualization of increased release of thyroid hormone. A sonogram was done, and a follow-up blood panel was ordered, confirming the patient's diagnosis of hyperthyroidism post COVID-19 recovery.

Indexed as

clinical endocrinologycovid-19covid induced hyperthyroidismhyperthyroidismsonogramthyroid disorderthyroiditisthyrotoxicosis

Identifiers

PMID37489189
PMCPMC10363334
OpenAlexW4381802956

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.